Evogene Receives Notice Of Allowance For U.S. Patent Titled 'BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY'
Portfolio Pulse from Benzinga Newsdesk
Evogene has received a Notice of Allowance for a U.S. patent titled 'Biomarkers and Methods for Detection of Seizures and Epilepsy'. This patent could potentially strengthen the company's intellectual property portfolio and provide a competitive edge in the healthcare sector.
September 14, 2023 | 6:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The allowance of a new patent for Evogene could potentially enhance its intellectual property portfolio and provide a competitive advantage in the healthcare sector.
Patents provide companies with a competitive edge by protecting their inventions from being used by competitors. This new patent could potentially enhance Evogene's intellectual property portfolio and provide a competitive advantage in the healthcare sector, which could positively impact the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100